rs386833507
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000112.4(SLC26A2):c.55G>T(p.Gly19*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000112.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A2 | ENST00000286298.5 | c.55G>T | p.Gly19* | stop_gained | Exon 2 of 3 | 1 | NM_000112.4 | ENSP00000286298.4 | ||
SLC26A2 | ENST00000433184.1 | c.55G>T | p.Gly19* | stop_gained | Exon 3 of 3 | 4 | ENSP00000405496.1 | |||
SLC26A2 | ENST00000690410.1 | n.287G>T | non_coding_transcript_exon_variant | Exon 2 of 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461838Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727220
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Diastrophic dysplasia;C0265274:Achondrogenesis, type IB;C1847593:Multiple epiphyseal dysplasia type 4;C1850554:Atelosteogenesis type II Pathogenic:2
- -
This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gly19*) in the SLC26A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC26A2 are known to be pathogenic (PMID: 7923357, 10482955, 11241838). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56026). This variant is also known as 82G>T G19X. This premature translational stop signal has been observed in individual(s) with diastrophic dysplasia (PMID: 11241838). -
Achondrogenesis, type IB Pathogenic:1
- -
Sulfate transporter-related osteochondrodysplasia Pathogenic:1
Variant summary: SLC26A2 c.55G>T (p.Gly19X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.532C>T, p.Arg178X and c.1724delA, p.Lys575fsX10; ). The variant was absent in 31182 control chromosomes (gnomAD and publication). The variant, c.55G>T, has been reported in the literature in only one individual affected with diastrophic dysplasia (Rossi_2001). This report does not provide unequivocal conclusions about association of the variant with Sulfate Transporter-Related Osteochondrodysplasia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Diastrophic dysplasia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at